US Stock MarketDetailed Quotes

RIGL Rigel Pharmaceuticals

Watchlist
  • 1.090
  • +0.040+3.81%
Close May 1 16:00 ET
  • 1.090
  • 0.0000.00%
Post 17:56 ET
191.19MMarket Cap-7785P/E (TTM)

Rigel Pharmaceuticals Key Stats

Rigel Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings Estimates

May 7, 2024

Revenue(YoY)

31.47M

+20.72%
EPS(YoY)

-0.03

+64.08%

Buy

Apr 30, 2024

Rigel Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 33.438M--
May 7, 20242024/Q1-- / 31.472M--
Mar 5, 20242023/Q435.792M / 33.415M--
Nov 7, 20232023/Q328.134M / 27.201M--
Aug 1, 20232023/Q226.886M / 25.704M--
May 2, 20232023/Q126.070M / 24.073M--
Mar 7, 20232022/Q451.278M / 26.640M--
Nov 3, 20222022/Q322.410M / 22.610M--
Aug 2, 20222022/Q229.819M / 23.655M--
May 3, 20222022/Q116.735M / 17.544M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 33.438M--
May 7, 20242024/Q1-- / 31.472M--
Mar 5, 20242023/Q435.792M / 33.415M--
Nov 7, 20232023/Q328.134M / 27.201M--
Aug 1, 20232023/Q226.886M / 25.704M--
May 2, 20232023/Q126.070M / 24.073M--
Mar 7, 20232022/Q451.278M / 26.640M--
Nov 3, 20222022/Q322.410M / 22.610M--
Aug 2, 20222022/Q229.819M / 23.655M--
May 3, 20222022/Q116.735M / 17.544M--

Unlock Free Earnings Estimates

Rigel Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 30, 2024

Buy

  • Buy

    50.00%
  • Hold

    50.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg